CXCL10 is a powerful angiogenesis inhibitor that binds to CXCR3 receptors and suppresses melanoma’s angiogenesis by decreasing intra-tumor vascular density and boosting apoptosis and necrosis of malignant tissue [42]. This evidence concerns the gene CXCL10 and neoplasm.